Compare LIF & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LIF | MMED |
|---|---|---|
| Founded | 2008 | 1983 |
| Country | United States | United States |
| Employees | 547 | 2800 |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.3B |
| IPO Year | N/A | 2026 |
| Metric | LIF | MMED |
|---|---|---|
| Price | $49.07 | $16.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 10 |
| Target Price | ★ $75.58 | $22.56 |
| AVG Volume (30 Days) | 656.2K | ★ 1.2M |
| Earning Date | 05-12-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $36.21 | $15.99 |
| Revenue Next Year | $20.80 | $10.00 |
| P/E Ratio | $425.29 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $37.01 | $10.65 |
| 52 Week High | $112.54 | $17.86 |
| Indicator | LIF | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 42.94 | 63.33 |
| Support Level | $37.47 | $14.70 |
| Resistance Level | $55.84 | N/A |
| Average True Range (ATR) | 2.39 | 0.90 |
| MACD | -0.95 | 0.04 |
| Stochastic Oscillator | 10.20 | 73.31 |
Life360 is the world's largest family focused social network, with nearly 100 million monthly active users. Security-conscious families use the Life360 app to track each other's whereabouts and to track the location of their pets and personal belongings. Life360 also offers a suite of additional security features, such as driver safety monitoring, roadside assistance, and emergency dispatching. In the US, the Life360 app regularly ranks in the top 10 most popular social-networking apps and in the top 25 across all apps in terms of daily active users.
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.